Ahmed Yaseen

Работ: 6

Gilgamesh Ahliya University, Baghdad, Iraq. Electronic address: [email protected]

1. Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis

   Qamar Abuhassan, Ahmed Faisal Mutee, Abdulkareem Shareef +10

   СтатьяPancreatic and Hepatic Oncology ResearchClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.011933

2. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

   Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

   СтатьяLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.013240

3. Antibody therapies in glioblastoma: Overcoming micro-environmental barriers.

   Moeen F. Dababneh, Faris Anad Muhammad, Abdulkareem Shareef +10

   СтатьяGlioma Diagnosis and TreatmentPubMed2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.015092

4. Ferroptosis in cancer: integrating multi-omics, AI-driven biomarkers, and translational challenges

   ‎Anmar Ghanim Taki, Abdulkareem Shareef, Vimal Arora +10

   СтатьяFerroptosis and cancer prognosisClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.022814

5. Quercetin as a multi-targeted therapeutic candidate in oral cancers: molecular mechanisms and preclinical evidence

   Qamar Abuhassan, Omer Qutaiba B. Allela, Wadhah Hasan Alkhazali +10

   СтатьяPhytochemicals and Antioxidant ActivitiesMolecular Biology Reports2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.023293

6. Integrin-linked kinase (ILK) in hematologic malignancies: Bridging molecular mechanisms to therapeutic innovation

   Omer Qutaiba B. Allela, Abdulkareem Shareef, Ashishkumar Kyada +9

   СтатьяCell Adhesion Molecules ResearchBioimpacts2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.023956